• Home
    • About
    • Products
      • Press Release Distribution
      • Content Marketing
    • Newsroom
    • Contact Us
    • Account
      • Account
      • Dashboard
      • Registration
      • Login
OrbitNewswire

OrbitNewswire

  • Home
  • About
  • Products
    • Press Release Distribution
    • Content Marketing
  • Newsroom
  • Contact Us
  • Account
    • Account
    • Dashboard
    • Registration
    • Login

Pharma

Allecra’s Exblifep Effective in Hospital-Based Urinary Tract Infections

  • February 25, 2020
  • OrbitNewswire
  • Pharma
Exblifep is a combination of a novel extended-spectrum beta-lactamase inhibitor, enmetazobactam, and the fourth-generation cephalosporin cefepime.
Continue Reading

Migraine Market: Biopharma Companies Working Toward Treatments

  • February 25, 2020
  • OrbitNewswire
  • Pharma
BioSpace takes a look at some of the investigational products that could, one day, provide relief for migraine sufferers.
Continue Reading

‘Record high’ two million people at type II diabetes risk

  • February 25, 2020
  • OrbitNewswire
  • Pharma
There are 1,969,610 people registered with a GP who have non-diabetic hyperglycaemia, a condition which puts people at high risk of type II.
Continue Reading

GSK recruits Clover Biopharmaceuticals in latest coronavirus effort

  • February 25, 2020
  • OrbitNewswire
  • Pharma
GSK initially announced plans to make its pandemic vaccine adjuvant platform technology available at the beginning of February.
Continue Reading

‘Smart watches’ for Alzheimer’s discussed as numbers set to double by 2050

  • February 25, 2020
  • OrbitNewswire
  • Pharma
Alzheimer’s is a complex disease and one of the largest challenges facing healthcare today, with lots of failed treatments in past pipelines.
Continue Reading

EMA, FDA both accept filing of Novartis’ ofatumumab

  • February 25, 2020
  • OrbitNewswire
  • Pharma
In two head-to-head studies, ofatumumab demonstrated superiority over Aubagio in patients with relapsing forms of multiple sclerosis.
Continue Reading

AZ divests Movantik rights to RedHill

  • February 25, 2020
  • OrbitNewswire
  • Pharma
The divestment is expected to complete in the first quarter of 2020, subject to customary closing conditions and regulatory clearances.
Continue Reading

Novartis Shares Fall Following Post-Marketing Concerns Over AMD Drug Beovu

  • February 25, 2020
  • OrbitNewswire
  • Pharma
The ASRS issued a note to its members about concerns regarding reports of vasculitis, an inflammation of the blood vessels and other complications that can lead to the loss...
Continue Reading

Mallinckrodt Files Chapter 11 for its Generics Business as it Reaches $1.6 Billion Opioid Settlement

  • February 25, 2020
  • OrbitNewswire
  • Pharma
In addition to the settlement and bankruptcy, Mallinckrodt entered into a debt refinancing agreement, including an $800 million loan that will be used to repay some outstanding debt and...
Continue Reading

Bicycle and Genentech Forge Immuno-Oncology Collaboration Worth up to $1.7 Billion

  • February 25, 2020
  • OrbitNewswire
  • Pharma
In its announcement, Bicycle did not identify the cancer targets it will focus on in its collaboration with Genentech.
Continue Reading

Posts navigation

1 2 Next

Categories

  • Aerospace & Defense
  • Automotive
  • Consumer Electronics
  • Crypto Currency
  • Cyber Security
  • Distribution
  • E-Commerce
  • Finance
  • Health
  • Legal
  • Merger & Acquisition
  • Network Security
  • Pharma
  • Press Release
  • Uncategorized

Recent Posts

  • Did You Acquire Penumbra between August 3, 2020 and December 15, 2020? Class Action Deadline Notice – Contact Johnson Fistel
  • Looking Back On Pokemon’s 25th Anniversary: Trading Cards, Video Games And Happy Meals
  • IPO Outlook: Oscar Health And InnovAge Hit Markets This Week
  • Senate To Begin Deliberations This Week On Latest COVID-19 Relief Bill
  • Walmart Hires 2 Goldman Sachs Bankers To Lead New Fintech Venture

Contact US

  • info@orbitnewswire.com

About

OrbitNewswire helps you distribute the right message to the right people at the right time. We help small, medium and large scale enterprises and companies alike to reach out to their intended audience with a well crafted press release, significantly increasing your brand exposure and visibility.

Contact Info

  • +13097334339
  • support@orbitnewswire.com

Quick Pages

  • About Us
  • Contact Us
  • Newsroom
  • Privacy Policy
  • Terms of Service

© 2020 OrbitNewswire Inc. All Rights Reserved.